Trofosfamide
![]() | |
![]() | |
| Clinical data | |
|---|---|
| Trade names | Ixoten |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | By mouth (film-coated tablets) |
| ATC code | L01AA07 (WHO) |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
22089-22-1 |
| PubChem (CID) | 65702 |
| UNII |
H64JRU6GJ0 |
| KEGG |
D07252 |
| ChEMBL |
CHEMBL462019 |
| ECHA InfoCard | 100.040.686 |
| Chemical and physical data | |
| Formula | C9H18Cl3N2O2P |
| Molar mass | 323.58 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| | |
Trofosfamide (INN) is a nitrogen mustard alkylating agent.
It is sometimes abbreviated "TRO".[1]
References
- ↑ Jahnke K, Thiel E, Bechrakis NE, et al. (December 2008). "Ifosfamide or trofosfamide in patients with intraocular lymphoma". J. Neurooncol. 93 (2): 213–7. doi:10.1007/s11060-008-9761-8. PMID 19099202.
This article is issued from Wikipedia - version of the 8/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

